s - Skip to Content
0 - Access key details
1 - Back to top
2 - Header search

Tag: Medicaid

New York Medicaid Prescription Drug Expenditure Trends

The Menges Group was asked to update an analysis of New York’s Medicaid prescription drug expenditure growth over the past several state fiscal years (SFY). Based on our analysis of year-over-year trends since SFY2014, we anticipate that single-digit annual growth…

Nov. 5, 2018 Download Full Report

KEYWORDS:Expenditures, Medicaid, Prescription Drugs

Mid-Term Election Results and Medicaid Expansion

Our November Edition of the 5 Slide Series focuses on the 2018 election results and conveys some of the potential implications of these results regarding Medicaid expansion.

Nov. 1, 2018 Download 5 slide

KEYWORDS:Expansion, Medicaid, Policy

Medicaid MCO Quality Tabulations – NCQA Rating Year 2018-2019

October’s edition conveys some of our tabulations working with the recently published NCQA Medicaid health plan quality ratings for Rating Year 2018-2019. AmeriHealth Caritas and UnitedHealthcare are the two top-rated national chain organizations in terms of their average NCQA rating…

Oct. 1, 2018 Download 5 slide

KEYWORDS:Medicaid, Quality

Medicaid MCO Savings on Prescription Drug Costs – Therapeutic Class Level Comparisons

The September edition presents Medicaid data from our Pharmacy Practice, quantifying the differences in cost per prescription between the MCO and FFS settings in two selected high-volume therapeutic classes. In both drug classes (as occurs with Medicaid prescriptions overall), the…

Sep. 1, 2018 Download 5 slide

KEYWORDS:Medicaid, Prescription Drugs

Disproportionate Share Hospital (DSH) Payment Trends in Medicaid Expansion vs. Non-Expansion States

The August edition quantifies Medicaid DSH payments, showing the progression of DSH spending in each state from 2013-2017. The key takeaway is that Medicaid DSH has not dropped at all across the expansion states since 2013, even though this was…

Aug. 1, 2018 Download 5 slide

KEYWORDS:Expansion, Expenditures, Medicaid

Medicaid MCO Profitability, 2016-2017

Our July 2018 edition conveys summary data regarding the Medicaid MCO industry’s overall financial performance during CY2016 and CY2017.

Jul. 1, 2018 Download 5 slide

KEYWORDS:Financial Performance, Medicaid

Georgia Medicaid MCO Profile Report, 2016-2017

Our June 2018 edition summarizes the recent financial performance and quality performance for Georgia’s health plans, as an example of the information we often provide our clients using these datasets.

Jun. 1, 2018 Download 5 slide

KEYWORDS:Financial Performance, Medicaid

Assessment of Louisiana Medicaid’s Prescription Drug Management Performance and Preferred Drug List Policy Options

Legislation has been proposed in Louisiana to take the Medicaid preferred drug list (PDL) content responsibility away from the MCOs and shift it to a single state-determined PDL. The Menges Group assessed the impact of this policy option and estimated…

May. 16, 2018 Download Full Report

ADDITIONAL RESOURCES:

Executive Summary

KEYWORDS:Medicaid, Policy, Prescription Drugs

Assessment of Louisiana Medicaid’s Prescription Drug Carve-Out Option

Currently, Louisiana includes (carves in) the pharmacy benefit in its capitated contracts with Medicaid MCOs. During FFY2017, Louisiana had the nation’s most favorable Medicaid generic dispensing rate at 90.9% and the nation’s 8th best (lowest) cost per prescription. The Menges…

May. 15, 2018 Download Full Report

ADDITIONAL RESOURCES:

Executive Summary

KEYWORDS:Medicaid, Pharmacy Carve Out, Policy, Prescription Drugs

Hepatitis C Medication Market Share

The March 2018 edition of our 5 Slide Series tracks the national Medicaid market share and pre-rebate cost per prescription progression of curative Hepatitis C drugs from CY2014 through CY2017. The introduction of newer, lower cost-per-unit drugs has resulted in…

Mar. 1, 2018 Download 5 slide

KEYWORDS:Medicaid, Prescription Drugs